InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Engelhart James, Chief Financial Officer. Officer active across 1 company, notably Biohaven Pharmaceutical Holding Co Ltd.. Aggregated, 4 reports have been logged. Activity tracked since 25 November 2021. The latest transaction was disclosed on 3 October 2022 (Disposition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Engelhart James is the Chief Financial Officer and Strategic Advisor at Biohaven Pharmaceutical Holding Co Ltd. In this role, he oversees financial operations and contributes to the growth strategy of the company. His expertise in finance and risk management is essential for ensuring the financial health and sustainability of Biohaven.